Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation
Hahn, C. K., K. N. Ross, I. M. Warrington, R. Mazitschek, C. M. Kanegai, R. D. Wright, A. L. Kung, T. R. Golub, and K. Stegmaier. 2008. “Expression-Based Screening Identifies the Combination of Histone Deacetylase Inhibitors and Retinoids for Neuroblastoma Differentiation”. Proc Natl Acad Sci U S A 105: 9751-6.